Schuth Alexander O., CFO and Secretary of Denali Therapeutics Inc. ($DNLI), made two open market sales of company shares in the last year, totaling about $324 thousand. His most recent sale occurred on January 6, 2026. These transactions rank 7,398th out of 11,678 individual insiders, well below the average sale amount of nearly $8.6 million across 6.37 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 17218 | $16.50 | 806,577.0000 | 172,421,492 | 2.09% | 0.01% |
| Jan. 3, 2026 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Common Stock | 57700 | $0.00 | 823,795.0000 | 172,421,492 | 7.53% | 0.03% |
| Jan. 3, 2026 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Stock Option (right to buy) | 173100 | $0.00 | 173,100.0000 | 172,421,492 | 9999.99% | 0.10% |
| Aug. 12, 2025 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2937 | $13.58 | 766,095.0000 | 164,473,772 | 0.38% | 0.00% |
| Jan. 7, 2025 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2907 | $20.81 | 768,057.0000 | 164,473,772 | 0.38% | 0.00% |
| Jan. 6, 2025 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 12255 | $20.22 | 770,964.0000 | 164,473,772 | 1.56% | 0.01% |
| Jan. 3, 2025 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Stock Option (right to buy) | 162540 | $0.00 | 162,540.0000 | 164,473,772 | 9999.99% | 0.10% |
| Jan. 3, 2025 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Common Stock | 54180 | $0.00 | 783,219.0000 | 164,473,772 | 7.43% | 0.03% |
| Dec. 27, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Common Stock | 6708 | $5.28 | 729,039.0000 | 169,456,988 | 0.93% | 0.00% |
| Dec. 27, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Stock Option (right to buy) | 6708 | $0.00 | 46,671.0000 | 169,456,988 | 12.57% | 0.00% |
| Nov. 22, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Stock Option (right to buy) | 20516 | $0.00 | 124,562.0000 | 169,456,988 | 14.14% | 0.01% |
| Nov. 22, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Common Stock | 20516 | $0.68 | 722,331.0000 | 169,456,988 | 2.92% | 0.01% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 300 | $31.29 | 701,815.0000 | 169,456,988 | 0.04% | 0.00% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Stock Option (right to buy) | 15558 | $0.00 | 53,379.0000 | 169,456,988 | 22.57% | 0.01% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 12333 | $29.68 | 705,040.0000 | 169,456,988 | 1.72% | 0.01% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Common Stock | 15558 | $5.28 | 717,373.0000 | 169,456,988 | 2.22% | 0.01% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2925 | $30.72 | 702,115.0000 | 169,456,988 | 0.41% | 0.00% |
| Aug. 20, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2453 | $23.79 | 707,715.0000 | 137,370,897 | 0.35% | 0.00% |
| Aug. 21, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2547 | $24.78 | 701,815.0000 | 137,370,897 | 0.36% | 0.00% |
| Aug. 20, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 3353 | $23.54 | 704,362.0000 | 137,370,897 | 0.47% | 0.00% |
| Aug. 13, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2272 | $22.89 | 710,168.0000 | 137,370,897 | 0.32% | 0.00% |
| Feb. 14, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 20128 | $17.66 | 711,090.0000 | 137,370,897 | 2.75% | 0.01% |
| Feb. 13, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 2716 | $17.29 | 731,218.0000 | 137,370,897 | 0.37% | 0.00% |
| Feb. 8, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Stock Option (right to buy) | 50000 | $0.00 | 145,078.0000 | 137,370,897 | 25.63% | 0.04% |
| Feb. 8, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | M | Common Stock | 50000 | $0.68 | 733,934.0000 | 137,370,897 | 7.31% | 0.04% |
| Jan. 5, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | S | Common Stock | 9972 | $19.43 | 683,934.0000 | 137,370,897 | 1.44% | 0.01% |
| Jan. 3, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Stock Option (right to buy) | 161160 | $0.00 | 161,160.0000 | 137,370,897 | 9999.99% | 0.12% |
| Jan. 3, 2024 | Denali Therapeutics Inc. | $DNLI | Schuth Alexander O. | COFO and Secretary | A | Common Stock | 53720 | $0.00 | 693,906.0000 | 137,370,897 | 8.39% | 0.04% |